Skin Cancer

>

Latest News

FDA
FDA Approves Adjuvant Nivolumab for Stage IIB/C Melanoma

October 16th 2023

The FDA has approved adjuvant nivolumab to treat completely resected stage IIB/C melanoma.

Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma
Pembrolizumab Outperforms Ipilimumab in 7-Year Follow-Up of Patients With Advanced Melanoma

August 23rd 2023

melanoma
ASCO Updates Systemic Therapy Guidelines for Melanoma

August 17th 2023

FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases
FDA Approves Hepzato Kit for Metastatic Uveal Melanoma With Liver Metastases

August 15th 2023

Pills © Grycaj
Patients Are Concerned About Developing an Opioid Addiction Following Mohs Microscopic Surgery

August 1st 2023

Latest CME Events & Activities

PER's Breast Cancer Symposia in San Antonio

Register Now!

2023 Friday Satellite Symposia: Preceding the 65th ASH Annual Meeting and Exposition

Register Now!

A Focus on Acute Myeloid Leukemia

View More

The Latest on Acute Lymphocytic Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Show Me Your Care Plan™: Nursing Considerations for Applying the Latest Approaches Across Care Settings in Melanoma

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

© 2023 MJH Life Sciences

All rights reserved.